I agree! My error in assuming his previous buys were personal. Tells me he is buying for the long haul. The company is not being sold for a quick buck but they intend to own the drugs and license them.
If memory serves me, the large chunks he bought were for himself, the smaller amounts are in trust for his grandchildren and the irregular buying could be due to availability of funds.
Your ID was created today, however your language and vernacular is very familiar and I have a good idea as to who you are. I do not think this company is for sale. Dr. A wants to be remembered as the person who created this "magic" drug and all his statements and press releases have pointed in the direction of an effort towards an agreement with BP. I agree they are spending money and that implies something else and not negotiations for sale.
Agree everyone is waiting for news but they have stretched this period of no news beyond any reasonable time. If there is no news in the next few weeks, people will conclude that nothing is in the works ;there will be significant selling and will embolden the short sellers. IMO the next few weeks are critical.
I have noticed that since the announcement of prostate cancer results the SP has been remarkably stable without the release of any news. This is in contrast to SPHS which has gone down significantly. This is because every time the SP drops, significant buying comes in on Thursday and Friday so the SP stays in the same range, week to week. This I believe is the result of Robinson supporting the SP. I think he is not buying so much for his own benefit but to support the SP until we have some resolution to ongoing negotiations. As Looky said the more innovative the drug, the longer it will take to put a price on it.
No U are too delusional! P3 was positive only for the believers not the rest of the world, it would not be below a dollar if it was positive for the market.
U may be right, we shall see. I have no position in SPHS so does not really matter directly to me. What I find interesting is that my interpretation of the dilution at 1 plus dollar, half the staff being fired and people leaving is at such variance with the people on this board.
No EU trial going on, I checked, another lie.
The results were positive on the long term extensions but the long term extensions were not part of the original protocol. The FDA hates ambiguity and hence will ask for another trial (IMHO). Since the EU requires a trial in EU before approval in EU, it seems likely the trial will be in Europe. The trial will be small since safety is not an issue and is more in the nature of a confirmatory trial. Sometimes if the FDA is accommodating it can be a post approval trial.
I don't claim to know what is going on but I think there is some kind of deal making going on. Unfortunately Dr. A does not have a very strong pair of hands as the study went beyond the initially stipulated protocol and the other company knows we are not in a good situation financially, although we seem to have found funds to survive so far and pay the new crew. I suspect a lot of the delay is because the FDA is involved and the other company wants to be reasonably certain it knows what the FDA is thinking. We ran two large trials and there are no major side effects which is what the FDA is most concerned about. I think the FDA is definitely going to require a small additional confirmatory trial. They have to perform a small trial in EU to get approval and I think the delay is because they are thrashing out the details with both the FDA and EU equivalent. I think a similar situation exists for prostate cancer because all they need is two trials one in US and one in EU which could be done simultaneously.
I also think what happened this week with SPHS should strengthen their hands as it is obvious they have no competitor in this space. SPHS is on a path of slow motion self destruct.
Stop distorting my messages, what I wrote is perfectly clear and on the SPHS board. I would never write to you. You are clearly not of sane mind any more.
Cash only for mgmt to be paid while they look for new jobs. Cash is put in by by people who got a chance to short at 1.8 with good news so they are safe, will cover when stock is worthless. Seen the same story play out too many times.